Accendra Health (ACH) drops equity issuance plan, expects to appoint CEO successor by mid-September, and sells non-core assets for $45 million
Accendra Health (ACH) has abandoned plans for an at-the-market equity issuance program, citing recent market conditions. The company stated this cancellation will not affect its operating results or financial guidance. Accendra also announced it is selling two non-core assets for a combined total of approximately $45 million in cash, with minimal impact on Adjusted EBITDA. Additionally, the board expects to appoint a successor to current CEO Christopher Pesicka by mid-September 2026, ahead of his planned retirement by year-end.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
24H Trending
-
1
ASTER is up 27.87% in the past hour, currently trading at $0.701
-
2
ASTER (Aster) dropped 23.56% in 1 hour, currently trading at $0.5225
-
3
ASTER (Aster) rose 10.14% in the past 1 hour, currently trading at $0.6026
-
4
ASTER is up 20.91% in the past hour, currently trading at $0.6632
-
5
ASTER is up 17.01% in the past hour, currently trading at $0.6412
-
6
ASTER dropped 15.99% in 5 minutes, currently trading at $0.5723
-
7
ASTER surged 24.43% in the past hour, currently trading at $0.6835
-
8
ASTER (Aster) dropped 20.53% in 5 minutes, currently trading at $0.5442
-
9
ASTER is up 13.26% in the past hour, currently trading at $0.6209
-
10
CNBC: Megaspeed Hires External Counsel to Investigate Business and Supply Chain Reports, Says Alice Huang Left in 2025
Markets Today
Recommended Reading


